At a glance
- Originator Scotia Holdings [CEASED]
- Class Antipsychotics
- Mechanism of Action Phospholipase A2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 22 Nov 1999 Discontinued-II for Schizophrenia in United Kingdom (Unknown route)
- 14 Dec 1995 New profile
- 14 Dec 1995 Phase-II clinical trials for Schizophrenia in United Kingdom (Unknown route)